These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease. Al Tabaa O; Ghossan R; Combier A; Steelandt A; Thomas M; Avouac J; Allanore Y RMD Open; 2023 Feb; 9(1):. PubMed ID: 36754549 [No Abstract] [Full Text] [Related]
3. Safety and efficacy of rituximab in connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis. Xing NS; Fan GZ; Yan F; Liu YP; Zhang R Int Immunopharmacol; 2021 Jun; 95():107524. PubMed ID: 33721757 [TBL] [Abstract][Full Text] [Related]
4. Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease. León Román F; Pintado-Cort B; García-Casado D; Muñiz-González F; López García-Asenjo JA; Díaz-Rodríguez C; Montoro-López MN; Loucel-Bellino M; Recio-Moreno B; Rebollo-Garrido S; Martínez-Hernández Y; Cusacovich I RMD Open; 2023 Sep; 9(3):. PubMed ID: 37673443 [TBL] [Abstract][Full Text] [Related]
12. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review. Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP Autoimmun Rev; 2020 Feb; 19(2):102453. PubMed ID: 31838163 [TBL] [Abstract][Full Text] [Related]
13. Interstitial lung disease in the connective tissue diseases. Antin-Ozerkis D; Rubinowitz A; Evans J; Homer RJ; Matthay RA Clin Chest Med; 2012 Mar; 33(1):123-49. PubMed ID: 22365251 [TBL] [Abstract][Full Text] [Related]
14. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061 [TBL] [Abstract][Full Text] [Related]
15. An analysis of connective tissue disease-associated interstitial lung disease at a US Tertiary Care Center: better survival in patients with systemic sclerosis. Su R; Bennett M; Jacobs S; Hunter T; Bailey C; Krishnan E; Rosen G; Chung L J Rheumatol; 2011 Apr; 38(4):693-701. PubMed ID: 21285162 [TBL] [Abstract][Full Text] [Related]
16. Effects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease. Benad M; Koschel D; Herrmann K; Wiefel K; Kleymann A; Aringer M Clin Exp Rheumatol; 2022 Mar; 40(3):483-488. PubMed ID: 33635231 [TBL] [Abstract][Full Text] [Related]
17. Treatment of interstitial lung diseases associated with connective tissue diseases. Kobayashi A; Okamoto H Expert Rev Clin Pharmacol; 2012 Mar; 5(2):219-27. PubMed ID: 22390563 [TBL] [Abstract][Full Text] [Related]
18. The role of biologics in treatment of connective tissue disease-associated interstitial lung disease. Sharp C; Dodds N; Mayers L; Millar AB; Gunawardena H; Adamali H QJM; 2015 Sep; 108(9):683-8. PubMed ID: 25614613 [TBL] [Abstract][Full Text] [Related]